Schepens
Bert Schepens, Drongen BE
Patent application number | Description | Published |
---|---|---|
20110182897 | AMINO ACID SEQUENCES DIRECTED AGAINST ENVELOPE PROTEINS OF A VIRUS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates in part to amino acid sequences that are directed against and/or that can specifically bind to an envelope protein of a virus, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. | 07-28-2011 |
20110311515 | PULMONARY ADMINISTRATION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND CONSTRUCTS THEREOF - The present invention relates to a method wherein an immunoglobulin single variable domain (such as a Nanobody) and/or construct thereof are absorbed in pulmonary tissue. More particularly, the invention provides systemic delivery of an immunoglobulin single variable domain and/or construct thereof via the pulmonary route. | 12-22-2011 |
20130136744 | PULMONARY ADMINISTRATION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND CONSTRUCTS THEREOF - In one aspect, the invention relates to a method suitable for administering protein therapeutic molecules orally, sublingually, topically, intravenously, subcutaneously, nasally, vaginally, rectally or by inhalation so as to avoid inactivation, by using VHH polypeptides derived from Camelidae antibodies. The invention further relates to the said therapeutic molecules. The invention further a method for delivering therapeutic molecules to the interior of cells. The invention further relates to anti-IgE therapeutic molecules. | 05-30-2013 |
Bert Schepens, Gent BE
Patent application number | Description | Published |
---|---|---|
20130315916 | RESPIRATORY SYNCYTIAL VIRUS VACCINE - Described is a vaccine against Respiratory Syncytial Virus (RSV). More specifically, described is a recombinant subunit vaccine comprising the ectodomain of the RSV-encoded Small Hydrophobic (SH) protein. The ectodomain of SH is referred to as SHe. The ectodomain is typically presented as an oligomer, or a pentamer. Further described are antibodies, raised against the ectodomain or specific for the ectodomain, and their use for protecting a subject against RSV infection and/or for treatment of an infected subject. | 11-28-2013 |
Cornelius Petrus Elisabeth Schepens, Beuningen NL
Patent application number | Description | Published |
---|---|---|
20110002168 | Binary Logic Utilizing MEMS Devices - Embodiments disclosed herein generally relate to switches that utilize micro-electromechanical systems (MEMS). By replacing transistors in many devices with switches such as MEMS switches, the devices may be used for logic applications. MEMS switches may be used in devices such as FPGAs, NAND devices, nvSRAM devices, AMS chips and general memory logic devices. The benefit of utilizing MEMS devices in place of transistors is that the transistors utilize more space on the chip. Additionally, the MEMS devices can be formed in the BEOL without having any negative impacts on the FEOL or necessitating the use of additional layers within the chip. | 01-06-2011 |
Cornelius Petrus Elisabeth Schepens, Jr Beuningen NL
Patent application number | Description | Published |
---|---|---|
20090273971 | CONTINUOUSLY DRIVING NON-VOLATILE MEMORY ELEMENT - Embodiments discussed herein generally relate to utilizing non-volatile memory elements to continuously drive other circuitry. There are many advantages to utilizing non-volatile memory to continuously drive other circuitry. For example, back end of the line (BEOL) compatible process may be used to fabricate the non-volatile memory elements that does not affect any front end of the line (FEOL) devices. This allows for an earlier integration of non-volatile technology into the latest state-of-the-art semiconductor process nodes. This is specifically important for FPGA and CPLDs, which make use of the latest process nodes. | 11-05-2009 |
Cornelius Petrus Elisabeth Schepens, Beuningen BE
Patent application number | Description | Published |
---|---|---|
20090268503 | NON-VOLATILE MEMORY BITCELL - A non-volatile memory bitcell which comprises a first bistable cantilever module and a second bistable cantilever modules. The bistable cantilever modules have a shared output terminal and each has an input terminal and two actuating terminals. The first and second cantilever modules are arranged such that their states are complementary. The memory bitcell further includes buffering means arranged to prevent the flow of current from the shared output terminal and further arranged to indicate the states of the first and second cantilever modules. | 10-29-2009 |
Patric Johannes Schepens, Helmond NL
Patent application number | Description | Published |
---|---|---|
20140123241 | METHOD AND SYSTEM FOR ENABLING AND DISABLING EXECUTION OF COMPUTER INSTRUCTIONS - In a computer implemented method or system, users are enabled to associate usage rights with at least a first entity and a second entity. The first entity and second entity are selected from different ones of the module, a processing circuitry and the one or more files. Execution of the module is only enabled when the associated usage rights allow both use of the first entity by the second entity and use of the second entity by the first entity, i.e. mutual usage rights for at least two entities exist. Execution of the module is disabled when the associated usage rights prevent at least one of use of the first entity by the second entity and use of the second entity by the first entity. | 05-01-2014 |
Wim Bert Griet Schepens, Mechepens BE
Patent application number | Description | Published |
---|---|---|
20110195969 | AMIDE COMPOUNDS AS BOOSTERS OF ANTIVIRALS - The present invention relates to compounds that have CYP450 inhibiting properties and are therefore useful as boosters of certain drugs, i.e. they are able to increase at least one of the pharmacokinetic variables of certain drugs when co-administered. The invention further provides the use of said compounds as improvers of the bioavailability of certain drugs. Methods for the preparation of the compounds of the invention and pharmaceutical compositions comprising these compounds are also provided. | 08-11-2011 |
Wim Bert Griet Schepens, Wetteren BE
Patent application number | Description | Published |
---|---|---|
20090170855 | HIV INHIBITING 3,4-DIHYDRO-IMIDAZO[4,5-B]PYRIDIN-5-ONES - HIV inhibitory compounds of formula: | 07-02-2009 |
Wim Bert Griet Schepens, Mechelen BE
Patent application number | Description | Published |
---|---|---|
20100305073 | AMIDE COMPOUNDS AS BOOSTERS OF ANTIVIRALS - The present invention relates to compounds that have CYP | 12-02-2010 |
20120295920 | 5-AMINO-4-HYDROXYPENTOYL AMIDES - HIV inhibitors of formula | 11-22-2012 |
20140357577 | HIV Membrane Fusion Inhibitors - The present invention concerns an inhibitor of Human Immunodeficiency Virus (HIV) fusion with, or HIV entry in, a host cell comprising at least 24, but preferably 26, contiguous amino acids; the invention also relates to a pharmaceutical composition comprising said amino acids. | 12-04-2014 |